Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report
GLP-1 receptor agonists are not suitable for everyone
Depression or suicidal thoughts: Any noticeable changes in mood, behavior, or thoughtsespecially those that feel intense or unusualshould be shared with a healthcare provider right away
12 weeks (1x daily, 5-on/2-off) 4 vials 60 doses needed (5x12)
CrossRef Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019 Juhee Park, Kyeongjun Moon, Dong-Sook Kim Frontiers in Oncology.2022;[Epub] CrossRef Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman Journal of Drug Assessment.2022
This is the gold standard for proving a drug works, and for BPC-157, it doesn't exist